Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06290687 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

StatusWithdrawn
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Withdrawn Sponsor's reason: PI left institution Show 4 more changesShow less
    • Enrollment target: estimated 40 to confirmed 0
    • Study sites: 1 to 0
    • Eligibility criteria expanded, about 23 words
    • Secondary endpoints: details revised at 2 of 6 entries
  2. Start date: Jul 2026 to Sep 2026v10
  3. Start date: Jun 2026 to Jul 2026v9
  4. Start date: Feb 18, 2025 to Jun 2026v8
  5. Primary completion date: Jan 29, 2026 to Dec 29, 2026
    • Study completion date: Jan 29, 2027 to Dec 29, 2027
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2025 to Feb 18, 2025
    • Site details revised
    v6
  2. Start date: Jun 2025 to Aug 2025v5
  3. Start date: Mar 2025 to Jun 2025v4
  4. Start date: Aug 2024 to Mar 2025v3
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to determine if a partial cystectomy with extended pelvic lymph node removal will be effective at treating Muscle-Invasive Bladder Cancer instead of a complete cystectomy with extended pelvic lymph node removal. This clinical trial aims to determine the safety and oncologic efficacy of the intervention, and to examine patient-reported quality of life outcomes in participants. Participants will receive the standard pre-surgery treatment for approximately 4 to 6 weeks. After the pre-surgery treatment is completed, participants will undergo a partial cystectomy with extended pelvic lymph node dissection. After surgery, participants will receive adjuvant systemic therapy.
Trial Details
NCT Number NCT06290687
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)		 Malignant Neoplasm of Bladder, Muscle Invasive Bladder Carcinoma
Related terms Urinary Bladder Neoplasms
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov